$5.95
À la fermeture: Oct 15 EDT
$6.11
0.162.69%
Pré-commercialisation: 5:01 PM EDT
Comments
Loading...
Orientation et prévision
Karyopharm Therapeutics publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/11/2025 | KPTI | Karyopharm Therapeutics | FY | 2025 | — | — | — | $140.00M | $155.00M | $148.22M | |
05/12/2025 | KPTI | Karyopharm Therapeutics | FY | 2025 | — | — | — | $140.00M | $155.00M | $149.62M | |
02/19/2025 | KPTI | Karyopharm Therapeutics | FY | 2025 | — | — | — | $140.00M | $155.00M | $165.50M | |
01/13/2025 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $145.00M | $145.00M | $152.89M | |
01/13/2025 | KPTI | Karyopharm Therapeutics | Q4 | 2024 | — | — | — | $30.00M | $30.00M | $38.20M | |
11/05/2024 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $145.00M | $155.00M | $152.35M | |
08/06/2024 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $145.00M | $160.00M | $145.44M | |
05/08/2024 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $140.00M | $160.00M | $146.52M | |
02/29/2024 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $140.00M | $160.00M | $152.02M | |
01/08/2024 | KPTI | Karyopharm Therapeutics | Q4 | 2023 | — | — | — | $33.60M | $33.60M | $37.64M | |
01/08/2024 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $146.00M | $146.00M | $150.03M | |
11/02/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $145.00M | $160.00M | $151.17M | |
08/02/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $145.00M | $160.00M | $150.34M | |
05/04/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $145.00M | $160.00M | $157.37M | |
02/15/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $160.00M | $175.00M | $163.24M | |
01/09/2023 | KPTI | Karyopharm Therapeutics | Q4 | 2022 | — | — | — | $34.20M | $34.20M | $38.13M | |
01/09/2023 | KPTI | Karyopharm Therapeutics | FY | 2022 | — | — | — | $157.70M | $157.70M | $161.68M | |
11/03/2022 | KPTI | Karyopharm Therapeutics | FY | 2022 | — | — | — | $155.00M | $165.00M | $157.23M | |
08/04/2022 | KPTI | Karyopharm Therapeutics | FY | 2022 | — | — | — | $155.00M | $165.00M | $160.03M |
FAQ
Quelles sont les dernières directives pour Karyopharm Therapeutics (KPTI) ?
Il n'y a eu aucune orientation spécifique sur les ventes ou les bénéfices rapportée pour Karyopharm Therapeutics ces derniers mois.
Parcourir guidance et prévisions sur toutes les actions.